Literature DB >> 24510130

[PREFERE--open questions].

C Schäfer1, L Weißbach.   

Abstract

Mesh：

Year:  2014        PMID： 24510130     DOI： 10.1007/s00120-013-3258-6

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  14 in total

1.  Radical prostatectomy versus watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Christer Busch; Stig Nordling; Hans Garmo; Juni Palmgren; Hans-Olov Adami; Bo Johan Norlén; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

2.  Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly.

Authors:  Roderick C N van den Bergh; Stijn Roemeling; Monique J Roobol; Gunnar Aus; Jonas Hugosson; Antti S Rannikko; Teuvo L Tammela; Chris H Bangma; Fritz H Schröder
Journal:  Eur Urol       Date:  2008-09-17       Impact factor: 20.096

3.  Results from the Scandinavian Prostate Cancer Group Trial Number 4: a randomized controlled trial of radical prostatectomy versus watchful waiting.

Authors:  Lars Holmberg; Anna Bill-Axelson; Gunnar Steineck; Hans Garmo; Juni Palmgren; Eva Johansson; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

4.  Gleason score 6 adenocarcinoma: should it be labeled as cancer?

Authors:  H Ballentine Carter; Alan W Partin; Patrick C Walsh; Bruce J Trock; Robert W Veltri; William G Nelson; Donald S Coffey; Eric A Singer; Jonathan I Epstein
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

5.  Delayed versus immediate surgical intervention and prostate cancer outcome.

Authors:  Christopher Warlick; Bruce J Trock; Patricia Landis; Jonathan I Epstein; H Ballentine Carter
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

6.  Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.

Authors:  Julia H Hayes; Daniel A Ollendorf; Steven D Pearson; Michael J Barry; Philip W Kantoff; Susan T Stewart; Vibha Bhatnagar; Christopher J Sweeney; James E Stahl; Pamela M McMahon
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

7.  Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

Authors:  Pär Stattin; Erik Holmberg; Jan-Erik Johansson; Lars Holmberg; Jan Adolfsson; Jonas Hugosson
Journal:  J Natl Cancer Inst       Date:  2010-06-18       Impact factor: 13.506

8.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

Review 9.  An evidence review of active surveillance in men with localized prostate cancer.

Authors:  Stanley Ip; Issa J Dahabreh; Mei Chung; Winifred W Yu; Ethan M Balk; Ramon C Iovin; Paul Mathew; Tony Luongo; Tomas Dvorak; Joseph Lau
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2011-12

10.  Natural history of early, localized prostate cancer: a final report from three decades of follow-up.

Authors:  Marcin Popiolek; Jennifer R Rider; Ove Andrén; Sven-Olof Andersson; Lars Holmberg; Hans-Olov Adami; Jan-Erik Johansson
Journal:  Eur Urol       Date:  2012-10-13       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.